Piper Sandler Issues Pessimistic Forecast for Sotera Health (NASDAQ:SHC) Stock Price

Sotera Health (NASDAQ:SHC) had its price target cut by research analysts at Piper Sandler from $15.00 to $13.00 in a research report issued on Wednesday,Benzinga reports. The firm currently has a “neutral” rating on the stock. Piper Sandler’s price objective would indicate a potential upside of 15.04% from the stock’s current price.

Separately, Barclays cut their price target on shares of Sotera Health from $16.00 to $12.00 and set an “overweight” rating for the company in a report on Thursday, April 10th. Two research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $15.20.

Sotera Health Stock Up 4.0 %

Shares of SHC stock opened at $11.30 on Wednesday. The company has a debt-to-equity ratio of 4.91, a quick ratio of 2.61 and a current ratio of 2.88. The stock has a market cap of $3.21 billion, a PE ratio of 45.20 and a beta of 1.88. The business’s fifty day moving average is $11.61 and its 200-day moving average is $13.20. Sotera Health has a 1 year low of $9.53 and a 1 year high of $17.08.

Institutional Investors Weigh In On Sotera Health

Institutional investors and hedge funds have recently modified their holdings of the stock. Blue Trust Inc. boosted its position in shares of Sotera Health by 164.3% in the 4th quarter. Blue Trust Inc. now owns 1,834 shares of the company’s stock valued at $25,000 after purchasing an additional 1,140 shares during the period. Quarry LP acquired a new position in shares of Sotera Health in the fourth quarter worth about $28,000. GAMMA Investing LLC increased its position in shares of Sotera Health by 37.5% in the fourth quarter. GAMMA Investing LLC now owns 4,109 shares of the company’s stock worth $56,000 after acquiring an additional 1,121 shares in the last quarter. Tower Research Capital LLC TRC increased its position in shares of Sotera Health by 37.8% in the fourth quarter. Tower Research Capital LLC TRC now owns 5,975 shares of the company’s stock worth $82,000 after acquiring an additional 1,640 shares in the last quarter. Finally, Farther Finance Advisors LLC raised its holdings in shares of Sotera Health by 4,881.9% during the first quarter. Farther Finance Advisors LLC now owns 6,327 shares of the company’s stock valued at $70,000 after acquiring an additional 6,200 shares during the period. 91.03% of the stock is owned by institutional investors and hedge funds.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.